Publications
484 publications
- Date
- Relevance
-
Advice - Extension of conditional inclusion procedure for ataluren (Translarna®)
The National Health Care Institute has advised the Minister of Health, Welfare and Sport (VWS) to extend the conditional ...
-
GVS advice glucagon (Ogluo®) for the treatment of severe hypoglycaemia in adults and children aged 2 years and older
The National Health Care Institute assessed whether the administration of subcutaneous glucagon (administration under the skin) ...
-
Package advice for lock procedure medicinal product darolutamide (Nubeqa®) for the treatment of metastatic prostate cancer
The National Health Care Institute has assessed whether the medicinal product darolutamide in combination with docetaxel and ...
-
Package advice eptinezumab (Vyepti®) for the treatment of migraine
The National Health Care Institute has assessed whether the CGRP inhibitor eptinezumab (Vyepti®) can be reimbursed from the basic ...
-
Package advice for entrectinib and larotrectinib (Rozlytrek® and Vitrakvi®) for the treatment of adult and paediatric patients with solid tumours (cancer) with NTRK gene fusion
The National Health Care Institute has assessed whether the medicinal products entrectinib and larotrectinib (Rozlytrek® and ...
-
GVS advice potassium citrate and potassium hydrogen carbonate (Sibnayal®) for the treatment of distal renal tubular acidosis (dRTA)
The National Health Care Institute has assessed whether the combination preparation potassium citrate and potassium hydrogen ...
-
Additional GVS advice nirmatrelvir/ritonavir (Paxlovid®) for the treatment of COVID-19
The National Health Care Institute assessed whether the reimbursement conditions of the subcutaneous CGRP inhibitors erenumab ...
-
GVS advice on extension of List 2 reimbursement conditions of subcutaneous CGRP inhibitors
The National Health Care Institute assessed whether the reimbursement conditions of the subcutaneous CGRP inhibitors erenumab ...
-
Package advice on the lock procedure medicinal product lenvatinib (Lenvima®) for the treatment of endometrial carcinoma
The National Health Care Institute has assessed whether the medicinal product darolutamide in combination with docetaxel and ...
-
GVS advice avacopan (Tavneos®) for the treatment of certain patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
The National Health Care Institute has assessed whether avacopan (Tavneos®) can be included in the Medicine Reimbursement System ...